- Published on:
Havana, June 22 (Prensa Latina) Varied foreign press media highlighted today the news that Cuba´s anticovid vaccine candidate Abdala, reached 92.28 percent of effectiveness in clinical studies, phase III.
© 2016-2021 Prensa Latina
Latin American News Agency
Radio – Publications – Videos – News by the minute.
All Rigts Reserved.
St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .
Web Site developed by IT Division Prensa Latina.